Thereafter, a recent study showed that piR-30188 could regulate the expression of CEBPA by targeting lncRNA OIP5-AS1 at the post-transcriptional level, thus inhibiting the proliferation of glioma cells 22. Here, OIP5 is linked to central nervous system cancer.